Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRNB2 | P17787 | 1/20 | 0.47 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.47 |
| ▸ | CTSC | P53634 | 4/20 | 0.42 |
| ▸ | CTSK | P43235 | 2/20 | 0.42 |
| ▸ | BRD4 | O60885 | 2/20 | 0.41 |
| ▸ | TLR9 | Q9NR96 | 1/20 | 0.41 |
| ▸ | TLR8 | Q9NR97 | 1/20 | 0.41 |
| ▸ | TLR7 | Q9NYK1 | 1/20 | 0.41 |
| ▸ | PTGS2 | P35354 | 9/20 | 0.41 |
| ▸ | PTGS1 | P23219 | 3/20 | 0.41 |
| ▸ | KIF11 | P52732 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL903872 | 0.84 | KIF11 (0.40) | CHRNB2CHRNA4CTSCCTSKBRD4 | |
| SCHEMBL904009 | 0.82 | SLC6A2 (0.45) | CHRNB2CHRNA4CTSCCTSKPTGS2 | |
| SCHEMBL12017225 | 0.79 | CHRNB2 (0.46) | CHRNB2CHRNA4CTSCBRD4TLR9 | |
| SCHEMBL1937388 | 0.77 | SLC6A9 (0.46) | BRD4PTGS2PTGS1KIF11 | |
| SCHEMBL903884 | 0.77 | KIF11 (0.41) | BRD4PTGS2PTGS1KIF11 | |
| SCHEMBL903920 | 0.76 | GPR119 (0.50) | — | |
| SCHEMBL12017230 | 0.75 | CHRNB2 (0.46) | CHRNB2CHRNA4CTSCCTSKBRD4 | |
| SCHEMBL903910 | 0.75 | GPR119 (0.46) | PTGS2PTGS1 | |
| SCHEMBL15190030 | 0.73 | GPR119 (0.38) | BRD4PTGS2PTGS1KIF11 | |
| SCHEMBL903870 | 0.73 | GPR119 (0.46) | PTGS2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2012041158-A1 | TRICYCLIC COMPOUND, PREPARATION METHOD AND PHARMACEUTICAL USE THEREOF | 上海恒瑞医药有限公司 (CN) | 2012-04-05 | — | — | WO | disclosed |